Advanced Medical Solutions Group (LON:AMS) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Advanced Medical Solutions Group plc (LON:AMS) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 218.61 ($2.84) and traded as low as GBX 188.80 ($2.45). Advanced Medical Solutions Group shares last traded at GBX 197 ($2.55), with a volume of 557,270 shares traded.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 300 ($3.89) price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 18th.

Advanced Medical Solutions Group Price Performance

The stock has a 50 day simple moving average of GBX 225.04 and a two-hundred day simple moving average of GBX 219.32. The company has a market cap of £512.77 million, a price-to-earnings ratio of 4,780.00, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58.

Advanced Medical Solutions Group Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, October 25th. Stockholders of record on Thursday, September 26th were paid a GBX 0.77 ($0.01) dividend. This represents a dividend yield of 0.32%. The ex-dividend date was Thursday, September 26th. Advanced Medical Solutions Group’s dividend payout ratio (DPR) is presently 4,000.00%.

Insider Activity

In other Advanced Medical Solutions Group news, insider Grahame Cook purchased 48,864 shares of the firm’s stock in a transaction dated Thursday, October 10th. The shares were acquired at an average price of GBX 205 ($2.66) per share, with a total value of £100,171.20 ($129,906.89). Corporate insiders own 3.12% of the company’s stock.

About Advanced Medical Solutions Group

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.